- Breast biopsy needles are essential tools in diagnosing breast cancer and other abnormalities by enabling precise tissue extraction for histopathological examination. Their minimally invasive nature, combined with high diagnostic accuracy, makes them vital in both public and private healthcare settings across Latin America
- The growing demand for breast biopsy needles in Latin America is primarily fueled by increasing awareness of early breast cancer detection, rising incidence rates of breast cancer, and improved access to diagnostic imaging technologies like ultrasound and stereotactic mammography
- Brazil dominated the Latin America breast biopsy needle market with a market share of 41.3% in Latin America in 2024, driven by government-backed cancer awareness initiatives, a large patient pool, and the presence of advanced public and private diagnostic centers offering image-guided biopsy procedures
- Mexico is expected to be the fastest-growing country in the Latin America breast biopsy needle market during the forecast period of 2025 to 2032, owing to rising healthcare expenditure, expansion of diagnostic imaging services in rural and urban areas, and increased adoption of minimally invasive procedures across both public and private healthcare sectors
- The core needle segment dominated the Latin America breast biopsy needle market with a share of 46.7% in 2024, favored for its balance between accuracy and cost-efficiency. Meanwhile, the vacuum-assisted biopsy segment is projected to witness the fastest CAGR, supported by its enhanced tissue sampling capabilities and reduced need for repeat procedures
